Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 1, Pages 281
Publisher
MDPI AG
Online
2020-01-21
DOI
10.3390/jcm9010281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The utility of serum exosomal microRNAs in hepatocellular carcinoma
- (2019) Li Jun et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity
- (2019) Pit Ullmann et al. CANCER LETTERS
- 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
- (2019) KLCA Korean Liver Cancer Association et al. Gut and Liver
- Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review)
- (2018) Jing‑Hua Pan et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Latest development of liquid biopsy
- (2018) Alvin Ho-Kwan Cheung et al. Journal of Thoracic Disease
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
- (2017) Petra Vychytilova-Faltejskova et al. Oncogenesis
- miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
- (2016) Qiao Zhu et al. BMC CANCER
- Evidence-based clinical practice guidelines for liver cirrhosis 2015
- (2016) Hiroshi Fukui et al. JOURNAL OF GASTROENTEROLOGY
- The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
- (2016) J. Best et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening
- (2015) Li Jiang et al. MEDICINE
- Integrated systems for exosome investigation
- (2015) Maureen F. Peterson et al. METHODS
- MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues
- (2015) LI WANG et al. Molecular Medicine Reports
- MicroRNAs involved with hepatocellular carcinoma (Review)
- (2015) BIJING MAO et al. ONCOLOGY REPORTS
- Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
- (2015) Jian Zhang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
- (2014) Zhu-qing Zhang et al. Diagnostic Pathology
- miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs
- (2014) Cheng-gong Liao et al. Journal of Translational Medicine
- Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
- (2014) Hongwei Wang et al. Biomed Research International
- Cell-Cell Communication between Malaria-Infected Red Blood Cells via Exosome-like Vesicles
- (2013) Neta Regev-Rudzki et al. CELL
- MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells
- (2012) Qing-jun Li et al. TUMOR BIOLOGY
- miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
- (2011) N M A White et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More